More about Star Health and Allied Insurance Company Limited
Fundamentals for Star Health and Allied Insurance Company Limited
Regulatory Filings for Star Health and Allied Insurance Company Limited
The Hidden Cost of India's Electronics Assembly Push: A 40% E-Waste Surge and the Death of Affordable Repair
The Wedding Loan Trap: How India’s Microfinance Boom Turned Housewives Into Ghost Borrowers and Temple Brass Into EMI Cash
From Lifesaving Drugs to Sick Units: The Hidden Energy Crisis Inside India’s Pharma Clusters
From Price Pressures to Profit Power: The MSME Playbook Redefining India’s Economy
Fundamentals for Star Health and Allied Insurance Company Limited
Business Operations:
Sector: Financial ServicesIndustry: Insurance - Diversified
Star Health and Allied Insurance Company Limited provides health insurance products in India. It offers retail health insurance products for individuals, families, children, senior citizens, and persons with pre-existing medical conditions; group health insurance products for employer/employee and non-employer/employee groups, including small-to-medium enterprises; and personal accident and travel insurance products. The company also provides star women care insurance policy that provides surrogacy and oocyte donor covers; and star special care product that covers children diagnosed with autism and for outpatient specialized treatments. In addition, it offers star health assure insurance policy, star cancer care platinum insurance policy, star cardiac care insurance policy platinum, young star extra protect add-on cover, antyodaya shramik suraksha yojana, star group domestic travel insurance policy, smart health pro, star domestic travel insurance policy, as well as star group OPD care insurance product. The company offers its products through web aggregators, digital channels, agency channels, corporate agents, brokers, point of sale persons, insurance marketing firms, and other channels. Star Health and Allied Insurance Company was incorporated in 2005 and is based in Chennai, India.
Revenue projections:
STARHEALTH's revenue is projected to decrease from last year, a development that could lead investors to adopt a more cautious approach. A revenue decline can negatively affect profitability, signaling challenges for the company and making it less attractive for those seeking solid financial performance.
Financial Ratios:
| currentRatio | 0.000000 |
|---|---|
| forwardPE | 20.103922 |
| debtToEquity | 6.183000 |
| earningsGrowth | -0.398000 |
| revenueGrowth | 0.102000 |
| grossMargins | 0.196260 |
| operatingMargins | 0.037890 |
| trailingEps | 7.590000 |
| forwardEps | 25.500000 |
STARHEALTH's Forward PE is in an attractive range, meaning its stock price aligns well with earnings and isn't inflated. This creates room for growth, making it a solid investment opportunity for those looking to benefit from potential price appreciation.
Star Health and Allied Insurance Company Limited's low growth in both earnings and revenue signals a potential profit decline. This could be a sign of financial trouble, suggesting that the company's profitability might shrink in the near future.
Star Health and Allied Insurance Company Limited's negative gross and operating margins point to losses in both production and operations. This suggests the company is facing financial challenges and may need to address cost management or improve revenue generation.
Star Health and Allied Insurance Company Limited's forward EPS surpassing its trailing EPS signals projected growth in profitability, with the company expected to perform better this year. This forecast suggests that Star Health and Allied Insurance Company Limited's earnings will improve compared to the previous financial year, highlighting optimism in its financial outlook.
Price projections:
The price of STARHEALTH has repeatedly been close to the lower limit of price projections. This trend suggests that the stock may be underperforming, raising concerns among investors about future performance.
Insider Transactions:
STARHEALTH had 6 buy transactions while market price was at 474.1333312988281 per share.There were no buy transactions during the period under consideration.The higher volume of sells at Star Health and Allied Insurance Company Limited's current price levels could indicate a potential decline. If this selling trend persists, the stock might continue to fall as investor confidence wanes, leading to more downward pressure.
Recommendation changes over time:
With analysts showing a buy bias for STARHEALTH, investors may be more inclined to see the stock as an attractive investment. The favorable outlook could spur increased interest, positioning STARHEALTH as a safe and profitable place for investors to allocate their funds and seek growth.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst fundamentals.
Latest Regulatory Filings for NSE500
Companies with the best and the worst technicals.
₹90 Crore Bet Signals a Massive Shift in India’s Rural Economy
The Hidden Engine of Global Growth: Why India Is Becoming Impossible to Overlook
₹10,000 Crore Deep-Tech Pivot: Why Fund of Funds 2.0 Will Redraw India's Startup Map